PTC Advances Cystic Fibrosis Candidate On Encouraging Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Company is pursuing PTC124 in nonsense-mutation-mediated CF, a patient population of about 3,000 in the U.S.